Atrás
Rango del Día
$117.64
$121.24
Rango de 52 Semanas
$92.52
$212.00
Volumen
499,976
Promedio 50D / 200D
$144.78
/
$160.76
Cierre Anterior
$116.28
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -85.7 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -6.0 | 3.9 |
| Rev Growth 5Y % | 23.3 | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$210.91
+78.5%
Low: $184.00
High: $244.00
EPS Futuro
-$0.32
Ingresos Est.
880 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$2.40
$2.37 – $2.45
|
1.4 B | 1 |
| FY2028 |
$1.86
$1.57 – $2.38
|
1.2 B | 3 |
| FY2027 |
$0.83
$0.37 – $1.28
|
1 B | 8 |
Puntos Clave
Revenue grew 23.34% annually over 5 years — strong growth
Generating 34.52M in free cash flow
Capital efficient — spends only 6.20% of revenue on capex
Crecimiento
Revenue Growth (5Y)
23.34%
Revenue (1Y)26.24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net Margin-5.96%
Op. Margin-4.93%
Seguridad
Debt / Equity
N/A
Current RatioN/A
Interest Coverage-2.80
Valoración
P/E Ratio
-85.70
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.24% | Revenue Growth (3Y) | 23.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23.34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 747.14M | Net Income (TTM) | -44.55M |
| ROE | N/A | ROA | N/A |
| Gross Margin | 70.57% | Operating Margin | -4.93% |
| Net Margin | -5.96% | Free Cash Flow (TTM) | 34.52M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | -2.80 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -85.70 | P/B Ratio | N/A |
| P/S Ratio | 5.11 | PEG Ratio | 2.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.82B | Enterprise Value | N/A |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 747.14M | 591.84M | 492.68M | 410.92M | 322.83M |
| Net Income | -44.55M | -113.29M | -123.41M | -116.16M | -101.36M |
| EPS (Diluted) | -1.39 | -3.63 | -4.04 | -3.88 | -3.46 |
| Gross Profit | 527.25M | 407.53M | 331.81M | 281.63M | 213.57M |
| Operating Income | -36.81M | -115.51M | -125.16M | -113.78M | -99.94M |